๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan flag Japan ยท Delayed Price ยท Currency is JPY
2,056.00
-7.00 (-0.34%)
Nov 18, 2026, 3:30 PM JST

Santen Pharmaceutical Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
297,034291,624300,004301,965279,037266,257
Revenue Growth
1.91%-2.79%-0.65%8.22%4.80%6.67%
Gross Profit
175,251169,743171,027178,709166,087156,586
Operating Income
47,72046,22448,29552,18535,30035,875
Net Income
38,87237,36036,24726,634-14,95527,212
Earnings Per Share
120.65113.80103.6872.37-38.6067.97
EPS Growth
30.10%9.76%43.26%--298.44%

Revenue by Geography

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Japan
138,142146,812165,310175,608177,373173,633
China
31,99930,01128,92729,85821,54627,197
Asia (Exclude China)
38,26733,25230,09728,66624,11819,813
Europe, Middle East and Africa (EMEA)
86,82880,09774,32264,75652,51342,899
Others
1,7961,4511,349---
Total
297,032291,623300,005301,966279,038266,257

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
81,65780,87592,99794,58257,90383,014
Total Debt
-34,75234,22934,61036,20732,932
Net Cash (Debt)
81,65746,12358,76859,97221,69650,082
Net Cash Growth
28.47%-21.52%-2.01%176.42%-56.68%-5.04%
Net Cash Per Share
253.41140.46168.06162.9156.00125.06

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
49,63743,50060,92872,64937,14746,043
Capital Expenditures
-8,332-6,844-6,662-9,319-17,277-17,344
Free Cash Flow
41,30536,65654,26663,33019,87028,699
Free Cash Flow Growth
6.40%-32.45%-14.31%218.72%-30.76%-17.22%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
59.00%58.21%57.01%59.18%59.52%58.81%
Operating Margin
16.07%15.85%16.10%17.28%12.65%13.47%
Pretax Margin
16.72%16.27%15.83%9.89%-2.08%13.38%
Profit Margin
13.09%12.81%12.08%8.82%-5.36%10.22%
FCF Margin
13.91%12.57%18.09%20.97%7.12%10.78%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
42.00038.00036.00033.00032.00032.000
Dividend Per Share Growth
10.53%5.56%9.09%3.13%0%14.29%
Dividend Yield
2.04%2.13%2.54%2.14%2.83%2.61%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
17.0415.3713.3521.00-18.04
Forward PE
16.2016.0614.1217.0925.0316.26
P/FCF Ratio
16.0215.678.928.8321.3617.11
PS Ratio
2.231.971.611.851.521.84